Phaim Pharma Ltd
09355572
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
30/06/2025
total exemption full
Next accounts due
31/03/2027
Confirmation statement
Last: 24/11/2025
Due 08/12/2026
Industry
Officers
director · Since 15/12/2014
MEDICAL PRACTITIONER
BRITISH · UNITED KINGDOM · Age 50
Also on 5 other boards
director · Since 15/12/2014
MEDICAL PRACTITIONER
BRITISH · ENGLAND · Age 62
Also on 5 other boards
director · Since 15/12/2014
MEDICAL PRACTITIONER
HUNGARIAN,AMERICAN · UNITED KINGDOM · Age 75
director · Since 15/05/2019
EXECUTIVE DIRECTOR
BRITISH · ENGLAND · Age 61
Also on 4 other boards
director · Since 01/09/2022
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 69
Also on 2 other boards
Persons with Significant Control
Prof Piers Edward Francis Daubeney
British · England · Age 62
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Hiam Orban Nee Jalahey
Hungarian · England · Age 78
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Nara Daubeney
British · United Kingdom · Age 50
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
Dr Tihamer Orban
Hungarian · United Kingdom · Age 75
16, Great Queen Street, London, WC2B 5AH
Notified 06/04/2016
CompanyRankvs 2864+ SIC 72110 peers23
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
a valid expectation that sufficient funding can be secured. The company has already secured some funding from investors following the year-end date. Accordingly, the directors continue to adopt the going concern assumption in the preparation of these financial statements. Nonetheless, the progression of the clinical trials and the need for further funding give rise to a material uncertainty that m
Key FinancialsYear ending 30/06/2025
Net Worth
-£911k
Balance sheet strength
Cash
£98
Cash in the bank
Net Current Assets
-£911k
Working capital
Current Assets
£18k
Current Liabilities
£930k
Debtors
£18k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.02 | -£120k |
| 2024 | 0.08 | -£14k |
| 2023 | 0.16 | — |
Derived from filed accounts. Not audited figures.